NASDAQ:ITRM

Iterum Therapeutics Earning Date

USA |NASDAQ |USD

ITRM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 15, 2021 Sep 2021 $0.12 $-0.04 $-0.34
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 15, 2021 Sep 2021 $0.00 $0.00 $0.00

Iterum Therapeutics's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 2021.

ITRM Earnings Date & History Chart

ITRM Earnings & Revenue Forecast

ITRM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.05 $-0.05 $-0.05
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $-0.28 $-0.28 $-0.28
Dec 2022 2 $-0.23 $-0.27 $-0.19

ITRM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.05 $-0.13 $-0.15
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.28 $-0.35 $-0.49
Dec 2022 0 / 0 $-0.23 $-0.24 $-0.36

ITRM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $0.00 $0.00 $0.00
Dec 2022 2 $0.00 $0.00 $0.00

ITRM Earnings Date & Revenue History

ITRM Earnings History

|
Show More
Show More

ITRM Revenue History

|
Show More
Show More

Iterum Therapeutics Next Earnings Date & Report

ITRM Next Earnings Date & Report Preview: Sep 2021 (FQ)

ITRM's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 2 analysts, the average EPS estimation for Iterum Therapeutics's next quarterly earnings is $0.12, with a low EPS estimation of $-0.05, and a high estimation of $0.29.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.12, the last 2 month trend is $0.10, and the 3 month trend is $-0.06.

Based on 2 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Iterum Therapeutics Previous Earnings Dates & Reports

ITRM Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Iterum Therapeutics's previous earnings date was Aug 13, 2021 for its fiscal quarter ended Jun 30, 2021.

ITRM's earnings per share (EPS) was $-0.04, beating the consensus analysts forecast of $-0.06 by 33.33%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -20.00%, and higher than the same period a year before (Jun 2020) by -92.86%.

Revenues were $0.00.

The company reported a net income of $7.80M.

Free cash flow for the quarter was $-8.34M , compared to $-1.13M last quarter and $-13.69M a year before.

ITRM ended the quarter with $25.69M in total debt, a decrease of -38.12% compared to the previous quarter, and a decrease of -33.69% compared to the same quarter a year before.

ITRM Previous Earnings Date & Report Recap: Dec 2020 (FY)

Iterum Therapeutics's previous annual earnings date was Mar 12, 2021 for its fiscal year ended Dec 31, 2020.

ITRM's earnings per share (EPS) was $-1.91, beating the consensus analysts forecast of $-2.44 by -21.72% , and higher than the previous year's EPS (Dec 2019) by -73.14%.

Revenues were $0.00.

The company reported a net income of $-52.01M.

Iterum Therapeutics reported a free cash flow of $-54.54M for its fiscal year, compared to $-78.91M a year ago.

The company ended the fiscal year with $42.34M in total debt, an increase of 215.37% compared to the previous year.